Physician profile
Esther Min
NPI 1962796185
$1,480.77
in general payments reported to CMS, 2019-2025
23 companies · $68.99 in 2025
The $68.99 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $128 · 2020: $144 · 2021: $358 · 2022: $246 · 2023: $386 · 2024: $150 · 2025: $68.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $520 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $519.65 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $454.27 | 2019-2023 | |
| Astellas Pharma US INC | $180.24 | 2019-2024 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $175.00 | 2021-2025 | |
| Therapeuticsmd, INC. | $83.48 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $66.11 | 2020-2024 | Gardasil 9, Gardasil |
| Coopersurgical, INC. | $62.60 | 2021-2024 | Paragard T 380a, Paragard T 380a |
| Daiichi Sankyo INC. | $51.60 | 2021-2022 | |
| Myriad Women'S Health, INC. | $48.70 | 2023 | Myrisk |
| Organon LLC | $42.89 | 2022-2024 | |
| Intuitive Surgical, INC. | $35.09 | 2022 | |
| Myovant Sciences INC. | $30.58 | 2021 | |
| Minerva Surgical, INC | $28.23 | 2021-2023 | |
| Medicem INC. | $27.78 | 2023 | |
| Baxter Healthcare | $23.91 | 2022 | |
| Hologic Sales and Service, LLC | $22.20 | 2024 | Novasure, Fluent Fluid Management System, Myosure Tissue Removal Device |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Meditrina | $21.59 | 2021 | |
| Supernus Pharmaceuticals, INC. | $20.41 | 2025 | Qelbree |
| Sage Therapeutics, LLC | $20.41 | 2025 | Zurzuvae |
| Amag Pharmaceuticals, INC. | $20.31 | 2019 | |
| Exeltis, USA INC. | $19.17 | 2019 | |
| Agile Therapeutics, INC. | $18.65 | 2023 | Twirla |
| Mayne Pharma Commercial LLC | $15.89 | 2022 | |
| Dysis Medical, INC. | $11.66 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Esther Min listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.